Surveillance for Adverse Events Following Influenza Immunization

CompletedOBSERVATIONAL
Enrollment

7,645

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
InfluenzaVaccines Adverse Reaction
Trial Locations (7)

Unknown

BC Children's and Women's Hospital, Vancouver, Vancouver

University of British Columbia,, Vancouver

Canadian Center for Vaccinology, Halifax, Halifax

The Ottawa General Hospital,, Ottawa

Mount Sinai Hospital, Toronto, Toronto

Centre Hospitalier et Universitaire de Sherbrooke, Sherbrooke

G1V 4V2

Centre Hospitalier Universitaire de Québec, Québec

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Institut National en Santé Publique du Québec

OTHER

collaborator

Laval University

OTHER

collaborator

CHU de Quebec-Universite Laval

OTHER

collaborator

Mount Sinai Hospital, Canada

OTHER

collaborator

IWK Health Centre

OTHER

collaborator

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER

collaborator

The Ottawa Hospital

OTHER

collaborator

University of British Columbia

OTHER

lead

PHAC/CIHR Influenza Research Network

OTHER_GOV

NCT01318876 - Surveillance for Adverse Events Following Influenza Immunization | Biotech Hunter | Biotech Hunter